Literature DB >> 30240151

Relative abundance of nasal microbiota in chronic rhinosinusitis by structured histopathology.

Hannah N Kuhar1, Bobby A Tajudeen2, Mahboobeh Mahdavinia3, Ashley Heilingoetter1, Ashwin Ganti1, Paolo Gattuso4, Ritu Ghai4, Pete S Batra2.   

Abstract

BACKGROUND: Chronic rhinosinusitis (CRS) is an inflammatory disease process with several different phenotypes. Recent data has shown that CRS phenotypes maintain distinct nasal microbiota that may predict surgical outcomes. Nasal microbiota and structured histopathologic reporting have the potential to further differentiate subtypes and provide additional insight into the pathophysiology of CRS.
METHODS: Sinus swabs collected during functional endoscopic sinus surgery (FESS) were studied by polymerase chain reaction analysis of 16S ribosomal RNA. A structured histopathology report of 13 variables was utilized to analyze sinus tissue removed during FESS. Histopathology variables and relative abundance of nasal microbiota were compared among CRS patients.
RESULTS: A total of 51 CRS patients who underwent FESS were included. Relative abundance of the Firmicutes phylum in nasal microbiota of CRS patients was associated with presence of neutrophilic infiltrate (27.47 ± 44.75 vs 9.21 ± 11.84, p < 0.029), presence of mucosal ulceration (47.67 ± 45.52 vs 13.27 ± 26.48, p < 0.041), presence of squamous metaplasia (5562.70 ± 2715.66 vs 3563.73 ± 2580.84, p < 0.035), and absence of Charcot-Leyden crystals (5423.00 ± 3320.57 vs 679.94 ± 1653.66, p < 0.001). Relative abundance of the Bacteroidetes phylum in nasal microbiota of CRS patients was associated with increased severity of inflammatory degree (p < 0.004) and presence of mucosal ulceration (p < 0.004).
CONCLUSION: Distinct histopathologic features of CRS are associated with relative abundance of nasal microbiota phyla, specifically Firmicutes and Bacteroidetes. These findings contribute to the growing body of literature on microbiota in sinonasal disease and may have important implications for understanding pathophysiologic mechanisms of CRS subtypes and disease management.
© 2018 ARS-AAOA, LLC.

Entities:  

Keywords:  alpha diversity; chronic rhinosinusitis; microbiome; relative abundance; sinus surgery; structured histopathology

Mesh:

Substances:

Year:  2018        PMID: 30240151     DOI: 10.1002/alr.22192

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  6 in total

1.  The influence of nasal bacterial microbiome diversity on the pathogenesis and prognosis of chronic rhinosinusitis patients with polyps.

Authors:  Weigang Gan; Hongting Zhang; Fengjuan Yang; Shixi Liu; Feng Liu; Juan Meng
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-22       Impact factor: 2.503

2.  Nasopharyngeal Microbiomes in Donkeys Shedding Streptococcus equi Subspecies equi in Comparison to Healthy Donkeys.

Authors:  Yiping Zhu; Shulei Chen; Ziwen Yi; Reed Holyoak; Tao Wang; Zhaoliang Ding; Jing Li
Journal:  Front Vet Sci       Date:  2021-04-22

Review 3.  The microbiome of the upper respiratory tract in health and disease.

Authors:  Christina Kumpitsch; Kaisa Koskinen; Veronika Schöpf; Christine Moissl-Eichinger
Journal:  BMC Biol       Date:  2019-11-07       Impact factor: 7.431

Review 4.  Association Between Microbiota and Nasal Mucosal Diseases in terms of Immunity.

Authors:  Junhu Tai; Mun Soo Han; Jiwon Kwak; Tae Hoon Kim
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

5.  Age-Associated Changes of Nasal Bacterial Microbiome in Patients With Chronic Rhinosinusitis.

Authors:  Fang Chen; Wenxiang Gao; Chaosheng Yu; Junzheng Li; Feng Yu; Meng Xia; Jiajian Liang; Jianbo Shi; Yinyan Lai
Journal:  Front Cell Infect Microbiol       Date:  2022-02-17       Impact factor: 5.293

6.  Effects of long-distance transportation on blood constituents and composition of the nasal microbiota in healthy donkeys.

Authors:  Fuwei Zhao; Guimiao Jiang; Chuanliang Ji; Zhiping Zhang; Weiping Gao; Peixiang Feng; Haijing Li; Min Li; Haibing Liu; Guiqin Liu; Humberto B Magalhaes; Jianji Li
Journal:  BMC Vet Res       Date:  2020-09-15       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.